Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 12K | 44K | 86K | 98K |
Selling general and admin | 485K | 913K | 722K | 1.1M |
Other operating expenses | — | — | — | — |
Operating income | -676K | -2.3M | -2.2M | -2.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 63K | 64K | 176K | 92K |
Other income expense | -25.1M | -11.1M | 129K | -301K |
Pretax income | -25.9M | -13.5M | -2.2M | -3.0M |
Tax provision | — | — | — | — |
Net income | -25.9M | -13.5M | -2.2M | -3.0M |
Basic EPS | -0.2 | -0.1 | 0.0 | — |
Diluted EPS | -0.2 | -0.1 | 0.0 | — |
Basic average shares | 202.4M | 192.0M | 182.8M | — |
Diluted average shares | 202.4M | 192.0M | 182.8M | — |
EBITDA | -497K | -957K | -808K | -1.5M |
Net income from continuing op. | -25.9M | -13.5M | -2.2M | -3.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |